Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf RegionCompleted
NCT04916509N/AUpdated Jun 2, 2026
Sponsor: Pfizer
Breast Neoplasms
Qatar, Saudi Arabia, United Arab Emirates
A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaCompleted
NCT01692886Phase 3Updated Jun 2, 2026
Sponsor: Pfizer
Pneumococcal Infection
China
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)Completed
NCT05709158N/AUpdated Jun 2, 2026
Sponsor: Pfizer
Breast Cancer
United States
A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in AustraliaCompleted
NCT06624020N/AUpdated Jun 2, 2026
Sponsor: Pfizer
Breast Neoplasms
Australia
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.Recruiting
NCT07543380Phase 3Updated Jun 2, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
Japan
A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy AdultsCompleted
NCT05930925Phase 1Updated Jun 2, 2026
Sponsor: Pfizer
Healthy
United States
Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBCCompleted
NCT05505175N/AUpdated Jun 2, 2026
Sponsor: Pfizer
Breast Cancer · Breast Carcinoma
Brazil
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.Completed
NCT04881045Phase 1Updated Jun 2, 2026
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Squamous Cell Carcinoma of the Head and Neck · Ovarian Cancer
United States, Spain
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without DiabetesRecruiting
NCT06924320Phase 1, Phase 2Updated Jun 1, 2026
Sponsor: Pfizer
Obesity and Obesity-related Medical Conditions
United States
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 YearsCompleted
NCT07069309Phase 3Updated Jun 1, 2026
Sponsor: BioNTech SE
COVID-19 · SARS-COV-2 Infection
United States
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia BActive Not Recruiting
NCT03861273Phase 3Updated Jun 1, 2026
Sponsor: Pfizer
Hemophilia B
United States, Australia, Brazil, Canada, France +11 more
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]Recruiting
NCT05895786Phase 3Updated Jun 1, 2026
Sponsor: Pfizer
Myositis
United States, Argentina, Bulgaria, China, France +15 more
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerRecruiting
NCT02693535Phase 2Updated May 29, 2026
Sponsor: American Society of Clinical Oncology
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
United States, Puerto Rico
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in AdultsActive Not Recruiting
NCT06684743Phase 4Updated May 29, 2026
Sponsor: Tor Biering-Sørensen
RSV
Denmark, Spain
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or OverweightCompleted
NCT06712836Phase 2Updated May 29, 2026
Sponsor: Pfizer
Obesity · Overweight or Obesity
United States
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or OverweightActive Not Recruiting
NCT06973720Phase 2Updated May 29, 2026
Sponsor: Pfizer
Obesity · Overweight or Obesity
United States
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.Completed
NCT06321510N/AUpdated May 29, 2026
Sponsor: Pfizer
Lung Cancer
Taiwan
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)Active Not Recruiting
NCT05743244Phase 2Updated May 29, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 1
United States, Australia, Canada
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy ChildrenCompleted
NCT04816643Phase 3Updated May 28, 2026
Sponsor: BioNTech SE
SARS-CoV-2 Infection, COVID-19
United States, Brazil, Finland, Mexico, Poland +1 more
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder CancerCompleted
NCT07386847N/AUpdated May 28, 2026
Sponsor: Pfizer
Metastatic Urothelial Carcinoma · Urothelial Cancer · Urothelial Carcinoma · Locally Advanced or Metastatic Urothelial Carcinoma
United States
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B RespectivelyRecruiting
NCT05568719Phase 3Updated May 27, 2026
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Australia, Canada, South Korea, Sweden +2 more
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008Recruiting
NCT03275311N/AUpdated May 27, 2026
Sponsor: UNICANCER
Metastatic Breast Cancer
France
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)Recruiting
NCT06991257Phase 2Updated May 27, 2026
Sponsor: Pfizer
Heart Failure
United States, Brazil, Bulgaria, Canada, China +8 more
Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous FungiCompleted
NCT05630976Phase 4Updated May 27, 2026
Sponsor: Pfizer
Invasive Fungal Disease
China
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)Recruiting
NCT03848052N/AUpdated May 27, 2026
Sponsor: UNICANCER
Lung Cancer
France

Previous page Next page